Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma |
| |
| Authors: | Ying Jin Xin An Yu Chen Cai Ye Cao Xiu Yu Cai Qing Xia Yu Ting Tan Wen Qi Jiang Yan Xia Shi |
| |
| Institution: | (1) State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China; |
| |
| Abstract: | Purpose Bone is the most common site of metastases from nasopharyngeal carcinoma (NPC). Zoledronic acid (ZA) used to prevent skeletal-related
events (SREs) of bone metastases has shown anti-tumor effects; yet, no report has been found on the survival benefit of ZA
in NPC. This study aimed to evaluate whether ZA can bring survival benefits to patients with bone metastases from NPC. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
